Drug class in one race
KRAS G12D drugs for Non-Small Cell Lung Cancer
12 tracked KRAS G12D drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the KRAS G12D page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
3 Phase 31 Phase 22 Phase 1/23 Phase 13 preclinical / unstaged